日本語 
Fujitsu Limited, Sumitomo Mitsui Financial Group, Inc. and SoftBank Corp. have entered into a business alliance focused on building a Japan-developed healthcare platform aimed at tackling long-term pressure on the country’s healthcare system. The agreement was signed on May 18 and centers around improving healthcare sustainability under Japan’s universal health insurance framework.
The three companies plan to develop a data platform that securely manages and uses medical information based on individual consent. The idea is to connect hospital and healthcare system data with personal health data managed directly by users themselves. Using that combined data, the companies plan to develop AI agents that work like personalized health partners for individuals.
The platform and related applications will operate through Japan-based data centers as part of a domestically built healthcare infrastructure push. The companies want the system to support the full healthcare cycle, from daily health management and medical consultations to treatment and post-treatment follow-up.
Also Read: Perplexity AI Partners on Japan Health Infrastructure
Another major target is reducing inefficiencies across healthcare services. The alliance plans to look at issues like duplicate testing, repeated prescriptions, interrupted treatment, and also ways to stop disease progress that could be avoided, kind of early. By improving coordination and how care gets delivered, the companies think this effort might help rein in future healthcare cost jumps, estimated close to 5 trillion yen. At the same time it would support longer healthy life expectancy across Japan, overall.
English